Page last updated: 2024-11-02

pentoxifylline and Hematologic Neoplasms

pentoxifylline has been researched along with Hematologic Neoplasms in 1 studies

Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
List, AF1
Maziarz, R1
Stiff, P1
Jansen, J1
Liesveld, J1
Andrews, F1
Schuster, M1
Wolff, S1
Litzow, M1
Karanes, C1
Dahlberg, S1
Kirkhart, B1
Bianco, JA1
Singer, JW1

Trials

1 trial available for pentoxifylline and Hematologic Neoplasms

ArticleYear
A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.
    Bone marrow transplantation, 2000, Volume: 25, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Beha

2000